Rosiglitazone treatment of HIV-associated lipodystrophy syndrome:: impact on the bioavailability of antiretroviral compounds

被引：0
|
作者：
Oette, M
Göbels, K
Kurowski, M
Kroidl, A
Feldt, T
Wettstein, M
Häussinger, D
机构：
[1] Univ Dusseldorf, Gastroenterol Clin, D-4000 Dusseldorf, Germany
[2] Auguste Viktoria Krankenhaus, Berlin, Germany
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
115
引用
收藏
页码：L77 / L77
页数：1
相关论文
共 50 条
  • [21] Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy
    Ruiz, L
    Negredo, E
    Domingo, P
    Paredes, R
    Francia, E
    Balagué, M
    Gel, S
    Bonjoch, A
    Fumaz, CR
    Johnston, S
    Romeu, J
    Lange, J
    Clotet, B
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (03) : 229 - 236
  • [22] HIV-ASSOCIATED LIPODYSTROPHY AND EXERCISE
    Mutimura, E.
    Stewart, A.
    Crowther, N. J.
    [J]. SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY, 2006, 62 (02) : 2 - 4
  • [23] HIV-associated lipodystrophy: Pathogenesis, prognosis, treatment, and controversies
    Koutkia, P
    Grinspoon, S
    [J]. ANNUAL REVIEW OF MEDICINE, 2004, 55 : 303 - 317
  • [24] Treatment of altered body composition in HIV-associated lipodystrophy: Comparison of rosiglitazone, pravastatin, and recombinant human growth hormone
    Macallan, Derek C.
    Baldwin, Christine
    Mandalia, Sundihya
    Pandol-Kaljevic, Vjera
    Higgins, Nadine
    Grundy, Alan
    Moyle, Graeme J.
    [J]. HIV CLINICAL TRIALS, 2008, 9 (04): : 254 - 268
  • [25] HIV-associated lipodystrophy syndrome: overview and summary of case reports
    Reid, S
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (01) : 87 - 88
  • [26] Rosiglitazone in the treatment of highly active antiretroviral therapy-associated lipodystrophy in HIV-positive patients.
    Sutinen, JP
    Häkkinen, A
    Westerbacka, J
    Seppälä-Lindroos, A
    Vehkavaara, S
    Halavaara, J
    Järvinen, A
    Ristola, M
    Yki-Järvinen, H
    [J]. DIABETOLOGIA, 2002, 45 : A235 - A235
  • [27] Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?
    Gharakhanian, Shahin
    Boccara, Franck
    Capeau, Jacqueline
    [J]. AIDS, 2006, 20 (07) : 1061 - 1063
  • [28] Antiretroviral therapy in the treatment of HIV-associated nephropathy
    Atta, Mohamed G.
    Gallant, Joel E.
    Rahman, M. Hafizur
    Nagajothi, Nagapradeep
    Racusen, Lorraine C.
    Scheel, Paul J.
    Fine, Derek M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (10) : 2809 - 2813
  • [29] Clinical management of HIV-associated lipodystrophy
    Pirmohamed, Munir
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (04) : 309 - 314
  • [30] Spotlight on Tesamorelin in HIV-Associated Lipodystrophy
    Sohita Dhillon
    [J]. BioDrugs, 2011, 25 : 405 - 408
12345